Carter Bankshares (CARE) Research & Development (2020 - 2026)

Carter Bankshares (CARE) has reported Research & Development for 7 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 56.06% year-over-year to $2.2 million; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (up 22.33% YoY), and the FY2025 full-year result was $5.7 million, up 15.88% from the prior year.
• Research & Development advanced to $2.2 million in Q2 2026 per CARE's latest filing, from $1.9 million in the prior quarter.
• Across five years, Research & Development topped out at $2.2 million in Q2 2026 and bottomed at $720000.0 in Q1 2023.
• Historically, Research & Development has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Research & Development jumped 74.64% in 2022, then sank 32.7% in 2023.
• Over 5 years, Research & Development stood at $1.6 million in 2022, then sank by 32.7% to $1.1 million in 2023, then soared by 36.68% to $1.5 million in 2024, then advanced by 2.54% to $1.5 million in 2025, then surged by 45.72% to $2.2 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $2.2 million, $1.9 million, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.